Outcome of 16th Annual General Meeting of the Members of the Company along with Proceedings, Voting Results and Scrutinizers report.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech held its 16th AGM on June 30, 2025 via video conferencing, where all 7 resolutions were passed with the requisite majority. Key items approved include the adoption of audited standalone and consolidated financial statements for FY25, declaration of a dividend of Re. 0.50 (25%) per equity share of face value Rs. 2, and the re-appointment of Mr. Sunil Chari as a director liable to retire by rotation. Shareholders also approved a material related party transaction with Unitop Chemicals Private Limited (90.35% in favour, as promoters did not vote on this), the appointment of M/s. Shah Patel & Associates as Secretarial Auditors, and ratification of remuneration for Cost Auditors M/s. R. Shetty & Associates. Out of 93,419 shareholders on record, 9 promoter group members and 35 public shareholders attended via VC, with about 87.37% of total equity shares voting on most resolutions.
Shareholders will receive a Rs. 0.50 per share dividend within 10 working days of the AGM. The strong voting support (over 99% in favour on most ordinary resolutions, including the dividend and re-appointment) signals broad shareholder agreement with management's direction, while the related party transaction saw notable dissent (~9.65% against), which is typical when promoters are excluded from voting.